Submitted by Anonymous (not verified) on 7 January 2026 - 16:02
Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 13, Status: Authorised